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Genetic studies of human diseases have identified many variants associated with
pathogenesis and severity. However, most studies have used only statistical association
to assess putative relationships to disease, and ignored other factors for evaluation. For
example, evolution is a factor that has shaped disease risk, changing allele frequencies
as human populations migrated into and inhabited new environments. Since many
common variants differ among populations in frequency, as does disease prevalence,
we hypothesized that patterns of disease and population structure, taken together, will
inform association studies. Thus, the population distributions of allelic risk variants
should reflect the distributions of their associated diseases. Evolutionary Triangulation
(ET) exploits this evolutionary differentiation by comparing population structure among
three populations with variable patterns of disease prevalence. By selecting populations
based on patterns where two have similar rates of disease that differ substantially from
a third, we performed a proof of principle analysis for this method. We examined three
disease phenotypes, lactase persistence, melanoma, and Type 2 diabetes mellitus. We
show that for lactase persistence, a phenotype with a simple genetic architecture, ET
identifies the key gene, lactase. For melanoma, ET identifies several genes associated
with this disease and/or phenotypes related to it, such as skin color genes. ET was less
obviously successful for Type 2 diabetes mellitus, perhaps because of the small effect
sizes in known risk loci and recent environmental changes that have altered disease
risk. Alternatively, ET may have revealed new genes involved in conferring disease risk
for diabetes that did not meet nominal GWAS significance thresholds. We also
compared ET to another method used to filter for phenotype associated genes,
population branch statistic (PBS), and show that ET performs better in identifying genes
known to associate with diseases appropriately distributed among populations. Our
results indicate that ET can filter association results to improve our ability to discover
disease loci.
Keywords: Genetic association, Population differentiation, Health disparity, SelectionIntroduction
As humans moved out of Africa, population patterns of genetic variation changed
dramatically, due to both random (e.g., genetic drift that can cause serial founder
events) and non-random (environment-specific selection) processes. The histories of
the different populations have therefore resulted in substantial differences among© 2016 Huang et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Huang et al. BioData Mining  (2016) 9:12 Page 2 of 18populations in allele frequencies at loci throughout the genome [1]. Many, if not most
of these differences, will have limited effect on phenotypic variation, but some allelic
substitutions may have implications for differences in phenotypic variation among pop-
ulations that may help inform us in the search for genes of biomedical significance.
Specifically, it could be hypothesized that the alleles that affect disease risk in multiple
populations should be distributed in ways that are consistent with differences in popula-
tion prevalence, such that risk alleles should be more frequent in those populations where
a given disease is more prevalent and less frequent where the disease is relatively rare.
Screening variants for differences in allele frequencies among populations may serve
as an effective filter to identify candidates for disease, even in the absence of prior
physiological evidence for disease-related function. However, because of the large number
of allele frequency differences among any two populations [2], pairwise comparisons be-
tween most human populations will generate too large a number of differentiated single
nucleotide polymorphisms (SNPs) to be of much practical use; any single comparison is
likely to generate too many possible loci, most of which are unlikely to be related to a
specific phenotype or class of phenotypes (Fig. 1a). We hypothesize that adding a third
population with similar disease prevalence to one of the other two populations being
compared increases our ability to define genomic regions of particular interest with
respect to disease or phenotypic variation by removing the vast majority of loci or SNPs
that, although highly differentiated, are unlikely to associate with phenotypes of interest
(Fig. 1b). The intersection of variants that have similar allele frequencies in populations
with similar disease prevalences, and different allele frequencies between populations with
different prevalences, should yield an enrichment of genes that associate with a given
disease. We define such variants as “appropriately distributed” with respect to a given
phenotype. Similarly, diseases that we will call “appropriately distributed” are those that
have prevalences distributed consistently with the allele frequency patterns of variation.
In this manuscript, we present a heuristic approach that incorporates genetic and
epidemiological information – namely, known disease distributions with pairwise alleleFig. 1 Limiting the number of SNPs by switching from pairwise to three-way comparison. The number of
SNPs identified in pairwise versus three-way population comparisons are illustrated by showing each two-analysis
and the three-way overlap. The number in each circle indicates the number of SNPs that are identified under a
particular FST threshold for a pairwise comparison; the numbers are shown in the lower left legend. For example,
a indicates there are 65119 SNPs under 95th percentile FST threshold in the comparison between CEU and YRI.
b shows that there is a significant decrease to 22 SNPs (center triangle) when using a three way comparison
under the thresholds of the same stringency
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genetic epidemiological analyses, such as genome wide association studies (GWAS).
We call this approach Evolutionary Triangulation (ET), as it represents comparisons of
three genetically distinct populations, assayed simultaneously. To assess levels of differ-
entiation, we use Wright’s FST [3], which is a metric that provides an estimate of the
level of allele frequency differences among populations. To assess the performance and
to determine the limits of our approach, we applied ET to a number of phenotypes that
vary in presumed genetic architecture, ranging from an essentially Mendelian trait
(lactase persistence), to diseases of increasing complexity, i.e., melanoma, representing
an oligogenic disease, and fasting glucose/Type 2 diabetes mellitus as a highly complex
disease with many genes of small effect.Methods
Index phenotype and population selection
We selected three index phenotypes in this study: lactase persistence, melanoma, and
Type 2 diabetes mellitus/fasting glucose, based on prior epidemiological data, most of
which were derived from the World Health Organization’s website (http://www.who.int/
en/) or current literature (Additional file 1: Table S1). Our selection of phenotypes was
further guided by the availability of genetic data from appropriate HapMap populations
that coincide with the epidemiological data (Additional file 1: Table S1). For instance,
melanoma is rare in South Asians and Africans, but common in Europeans (e.g. ~150 fold
greater prevalence than in South Asians), matching the HapMap populations GIH, YRI
and CEU. Additionally, these phenotypes represent a range of underlying genetic architec-
tures, allowing us to assess whether ET is applicable to a broad variety of traits, from
effectively Mendelian diseases to complex disorders with small effect sizes (e.g., odds
ratios as low as 1.04)(Table 1).Table 1 Genetic associations of the 85th/15th threshold ET genes with index diseases/traits
(CEU-GIH-YRI)
Index disease ET genes 5tha 10tha Odds ratiob
Lactase Persistence LCT Y Y Mendelian
Melanoma/Skin Neoplasms OCA2 3.16 [58]
SLC45A2 Y Y 2.78 [15]
TYRP1 1.15 [59]
XRCC1 0.60 [60]






IGF2BP2 Y 1.22 [65]
IL6 Y 1.29 [66]
SH2B1 Y 1.16 [67]
SREBF1 Y 1.17 [68]
a5th/10th: Y indicates ET genes identified under the 95th/5th or 90th/10th threshold, respectively
bLargest reported Odds ratio
cCase diagnosis is as defined in each reference
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We chose representative HapMap populations based on the prevalences of the index
phenotypes (Additional file 1: Table S1). We obtained all SNP allele frequency data for
unrelated individuals from the selected populations in the International HapMap
Project Phase III [4], which included 113 Utah residents with Northern and Western
European ethnicity (CEU), 84 Han Chinese from Beijing, China (CHB), 88 Tuscans
from Italy (TSI), 88 Gujarati Indians from Houston (GIH), 113 Yoruba from Ibadan,
Nigeria (YRI), 86 Japanese in Tokyo, Japan (JPT), and 50 Mexican Americans in Los
Angeles, California (MEX). CEU was a proxy for Northern European populations, CHB
and JPT for East Asian populations, TSI for Southern European populations, GIH for
South Asian populations, MEX for Central American Hispanic populations, and YRI
for West African populations.
To assess the population genetic differences we calculated unbiased estimates of FST
based on HapMap allele frequency data according to the Weir and Cockerham formula
[5]. For example, among the CEU, GIH and YRI, as shown in Fig. 1, the FST of each
SNP was calculated pairwise. ET SNPs (center triangle, Fig. 1b) were selected according
to the overlaps of high FST(CEU_GIH), high FST(CEU_YRI) and low FST(GIH_YRI).
Since we did not know a priori the appropriate levels of FST similarity/dissimilarity that
would enable us to detect genes associated with specific phenotypes, we used different
FST thresholds to yield different numbers of ET SNPs. We first chose a highly stringent
threshold, with the 95th percentile of FST indicating high differentiation and the 5th
indicating a high degree of similarity (Fig. 2). This allowed us to limit the number of
ET SNPs suitable for further hand-curated genetic association mining. We then applied
more lenient thresholds, namely the 90th percentile and the 85th percentile reflecting
high differentiation, and the corresponding 10th and 15th percentile reflecting suffi-
cient similarity. ET genes were defined as genes that were within 100 Kb upstream or
downstream of each ET SNP, according to NCBI Build 37. To further explore putative
associating loci we also examined the recombination landscape around ET detected
SNPs, using Locus Zoom ((http://locuszoom.sph.umich.edu/locuszoom/).Genetic association mining and identification of additional phenotypes
Genetic associations of ET genes with diseases were analyzed based on data retrieved
from the HuGE Navigator [6] (http://www.cdc.gov/genomics/hugenet/hugenaviga-
tor.htm), a human genome epidemiology knowledgebase that incorporates information
from PubMed abstracts as its core data source. We defined a “true” association as one
for which a gene had: (1) five or more HuGE publications significantly associating it
with a phenotype using the Genopedia function and p < 0.05 in any combination of
studied populations, or (2) GWAS evidence with a P value of less than 5 × 10−8 re-
ported in HuGE Navigator. Although negative GWAS results have been shown to cor-
relate with geography and FST [7], we chose to be conservative, ignoring negative
results as this is a proof of principle.
Additional phenotypes were noted if they too associated with ET genes in the HuGE
Navigator database. Other associating diseases were then assessed for their global
distributions to assess whether they are also similarly distributed to the index
phenotypes (Additional file 1: Table S1).
Fig. 2 FST distributions among ET comparisons of CEU, GIH and YRI populations. Shows the FST distributions
of CEU-GIH, CEU-YRI and GIH-YRI. Similar in the three distributions, most FST’s are less than 0.1, which means
that most SNPs are not differentiated greatly among population. The red dotted lines indicates the percentile
thresholds we use to generate ET SNPs. For example, for CEU-GIH and CEU-YRI we took SNPs having an FST
greater than or equal to 95th percentile, which are those to right of the red dotted lines. And for GIH-YRI, we
took SNPs having an FST less than or equal to than 5th percentile, which are those to left of the red dotted line.
By overlapping these three sets of SNPs, we could generate the ET SNPs
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To determine whether ET significantly enriched for genes that associated with the
index or other appropriately distributed phenotypes, we performed permutation testing.
Specifically, for each ET threshold we sampled from the genome the same number of
genes that were identified to be associated with appropriately distributed disease using
ET. We then verified using the same criteria as for ET how many of these genes were
associated with appropriately distributed disease based on the continental ancestry for
a given comparison. We used the empirical distribution to determine the p- value of
the ET analyses. The empirical distributions were determined by sampling the genome
10,000 times without replacement. We established the number of times that the same
number or more such genes were found by this random process.
Results
ET comparisons among populations were chosen to reflect the distribution of several
phenotypes, ranging from genetically simple to increasingly complex, that differ in
prevalence among HapMap populations. Estimated genetic complexity was based on
the number of GWAS identified genes and their effects sizes, extracted from the
NHGRI GWAS catalog (Additional file 2: Table S2). The index phenotypes we analyzed
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and Type 2 diabetes mellitus/fasting glucose. These phenotypes are likely related to evolu-
tionary adaptations to different environments, making the integration of evolutionary data
more promising.Lactase persistence
Lactase persistence is the ability to digest lactose in adulthood and is the inverse of
lactose intolerance [8]. More than 90 % of Northern European individuals have lactase
persistence. In contrast, about half of the population of Southern Europe, and most
Asians and Africans, have lactase persistence, as milk has been rarely consumed in
these regions (Additional file 1: Table S1). Evolutionary evidence indicates that there
has been strong selective pressure in populations with animal domestication and adult
milk consumption to maintain the ability to metabolize lactose after weaning [9].
The genetics of lactase persistence is relatively simple. The primary gene that affects
the phenotype is lactase (LCT) in the LCT-MCM6 locus on chromosome 2 [8], and the
identified variations are primarily cis-acting elements [10]. Interestingly, the variants
associated with lactase persistence in European and African pastoralist populations are
different, even though they are within the same upstream region of LCT [9]. In both
cases, the evidence indicates that all variants are under strong selection corresponding
to levels of animal milk consumption and pastoralist culture.
We applied ET to lactase persistence using three HapMap populations, CEU, TSI and
CHB. Using the 95th percentile threshold to define highly differentiated SNPs between
CEU/TSI and CEU/CHB, and the 5th percentile threshold to define similarly distributed
SNPs between TSI and CHB, we identified eight ET SNPs and eight ET genes (Additional
file 3: Table S3a). Seven of these SNPs were within ± 100 Kb of the LCT-MCM6 region
and, although more than 100 kb from LCT, the eighth was in the same region (Fig. 3). Of
note, the majority of the ET SNPs were bounded by distal recombination hotspots,
illustrating how we might refine locus boundaries (Additional file 4: Figure S1).
To assess the sensitivity of ET to varying levels of FST thresholds, we used multiple
thresholds ranging from the 80th/20th to the 90th/10th percentile. The significant over-
representation of the LCT-MCM6 signal still held under less stringent thresholds. Under
the 90th/10th threshold, we obtained 29 ET SNPs and 14 genes (Additional file 3:
Table S3b). Twenty of these SNPs were within ± 100 Kb of LCT-MCM6 region.
Under the 85th/15th threshold, we generated 33 ET SNPs and 14 genes (Additional file 3:
Table S3c). Again, twenty of these SNPs were within ± 100 Kb of LCT-MCM6 region.
Even using the 80th percentile threshold, with FST(CEU_CHB) and FST(CEU_TSI), and
the 20th percentile threshold, with FST(TSI_CHB), we generated 50 ET SNPs, of which 23Fig. 3 ET SNPs in vicinity of the LCT gene. Seven out of eight ET SNPs generated under the 95th/5th percentile
threshold are within 100 Kb of LCT loci. The eighth is to the right of the DARS gene, upstream of the LCT-MCM6
locus. (Coordinate only shows relative distance not indicating exact build 37 coordinates)
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other thresholds and populations are presented in Additional file 5: Table S4.
Based on the prevalence of lactase persistence in other populations [11] (Additional
file 1: Table S1), we also applied ET to CEU, YRI and GIH. Highly differentiated SNPs
between CEU and GIH and between CEU and YRI were compared to highly similar
SNPs between GIH and YRI. With the 95th/5th threshold, we identified 22 SNPs, of
which two were within ± 100 Kb of the LCT-MCM6 region (Additional file 6: Table S5).
Additionally, using the 95th/5th threshold, we were able to identify the LCT-MCM6
gene region in comparisons of CEU to CHB and LWK (HapMap East African), both of
which do not have a large amount of lactase persistence (data not shown).
Two way comparison for lactase persistence
As we hypothesized that adding a third population will improve the efficiency of filtering
for disease related variants, we investigated the number of genes revealed by only examin-
ing two-way comparisons to assess the improved precision derived from adding a third
population. To do this, we compared the percentage of SNPs that are within ±100 Kb of
the LCT-MCM locus in all two-way FST comparisons vs. the three-way FST comparison
(ET). Comparing only CEU to TSI under FST thresholds, ranging from 95th/5th to 85th/
15th, we found that for two-way FST comparisons at best 0.13 % of the generated signals
were located within the LCT-MCM region (95th/5th comparison). However, in the three-
way FST comparison, more than 60 % of the ET SNPs are located within ±100 Kb of the
LCT-MCM region (Fig. 4). Adding a third population greatly enriched the proportion of
variants related to the corresponding phenotype(s), demonstrating that the ET can better
resolve associating SNPs/genes.Fig. 4 Percentage of ET SNPs within ± 100 Kb of the LCT-MCM genic region. In all two-way comparisons, only a
small proportion (<0.2 %) of the SNPs are within ± 100 Kb of the LCT-MCM region. For example, the 95th
percentile FST threshold of two way comparison between CEU and TSI (red line) generates 68,106 SNPs, only
91 (0.133 %) of which locate within ± 100 Kb of the LCT-MCM region. In contrast, signals from the three way
comparison of FST (ET) more than 60 % of the ET SNPs are within the same region (blue line). The black line
represents the pairwise comparisons between CEU and CHB, while the green line represents between CHB
and TSI
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Melanoma was our second selected index phenotype. About 40 genes have been
associated with melanoma, according to HuGE Navigator, making it substantially
more complex than lactase persistence. The prevalence of melanoma varies with
latitude [12], a relationship likely due to dark skin being favored in regions of high
UV radiation, where it protects from skin damage, while still allowing adequate
vitamin D to be synthesized. At the same time, dark skin limits UV degradation of
folate in underlying skin layers, and low folate levels are associated with increased
risk of neural tube defects in utero [13]. In contrast, light skin is more common at
high latitudes where its presence promotes vitamin D biosynthesis in environments
with low ultraviolet radiation [14]. Melanoma is relatively common in populations
of European descent, but its prevalence is much lower in populations of South
Asian and African descent (Additional file 1: Table S1). Thus, applying ET analysis
to melanoma using the CEU, YRI and GIH populations (with CEU as the outlier
population) fits the population prevalence requirements for ET filtering.
Under the stringent 95th/5th percentile threshold we obtained 22 ET SNPs that
mapped to 33 ET genes (Additional file 6: Table S5a). One of these 33 genes, SLC45A2,
has previously been shown to associate with melanoma [15]. The ET SNP that
identified this locus, rs28117, is bounded both proximally and distally by recombination
hotspots, thereby providing additional resolution (Additional file 7: Figure S2). Under
the 90th/10th percentile threshold, we generated 168 ET SNPs which mapped to 230
ET genes. Under the least stringent 85th/15th percentile threshold, we generated 733
ET SNPs that mapped to 971 ET genes, four of which are known to associate with
melanoma (Table 1, Additional file 6: Table S5b, S5c).
This analysis also identified numerous other genes associated with diseases that are
distributed appropriately among these three populations. One example is multiple
sclerosis (MS), a complex disease with more than 80 genes that have been associated
with susceptibility, but each of these variants confers only a very small change in risk.
Collectively, these genes explain approximately 20 % of the genetics of MS [16, 17].
Similar to melanoma, the prevalence of MS is associated with latitude; the most prom-
inent correlating factor is ultraviolet radiation/vitamin D [18]. Recently, by showing
positive selection on MS associated loci, researchers proposed that MS might have
arisen due to pleiotropic effects of host resistance to pathogens over the course of
human history, where there has been significant selective pressure acting to increase
this resistance to pathogens [19]. Under the 90th/10th percentile threshold, we were
able to identify one gene, IL6, previously associated with MS. IL6 is of particular
interest as it has been associated with 15 diseases that are similarly distributed, several
of which are related to immune function, indicating strong pleiotropic effects
(Additional file 8: Table S6).
The ET analysis for melanoma also identified genes associating with many other
similarly distributed phenotypes (Additional file 8: Table S6). For example, ET detected
LCT under the most stringent 95th/5th FST percentile threshold, consistent with the
distribution of lactase persistence. Besides lactase persistence, ET genes under the least
stringent 85th/15th threshold have also been associated with other Mendelian disorders
having appropriate distributions among the three populations, such as oculocutaneous
albinism, glucosephosphate dehydrogenase deficiency and Smith-Lemli-Opitz Syndrome.
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DHCR7. Other disorders have also been associated with these ET genes, but the associ-
ation is not as direct. For example, G6PD has been associated with favism caused by
G6PD deficiency that can affect survival of the malaria parasite, Plasmodium falciparum
[20]. Malaria is much more common in South Asia and Africa than it is in northern
Europe, highlighting another appropriately identified genetic association. ET was also able
to capture genes that have been associated with complex diseases having appropriate
distributions among the three populations, for example, Vitamin D deficiency, which is
strongly correlated with skin color. DHCR7 and CYP24A1 have the largest reported effect
sizes for Vitamin D deficiency and were found using ET [21]. Interestingly, another ET
gene, BNC2, has also been associated with hair and skin color in a GWAS study [22]. As
melanoma is strongly associated with skin color, we expect that genes affecting skin color
would also appear. The evolutionary factors that drive these phenotypes are likely
common, emphasizing the ability of ET to detect genes that are pleiotropic. ET genes have
also been associated with other complex diseases, such as pulmonary tuberculosis,
multiple cancers, and Alzheimer’s disease, all of which have relatively large effect sizes
(Additional file 8: Table S6). ET comparisons also allowed us to identify key immune
regulators, such as IFNG and IL6, which associate with many phenotypes.
Type 2 diabetes mellitus/fasting glucose
Fasting glucose, although measured as a continuous trait, is reflective of Type 2 diabetes
mellitus prevalence. Because diabetes case criteria may differ among studies based on
variable diagnostic standards we chose to use fasting glucose as our index phenotype, as it
is a more objective but highy correlated trait representing the complex genetic architec-
ture of Type 2 diabetes. In the Mexican population, the average fasting glucose level is
higher than in Asian and Northern European populations. For this analysis, we used the
populations MEX, JPT, and CEU for ET analyses based on current epidemiological data.
We identified no genes that have been associated with Type 2 diabetes mellitus,
according to our criteria. Because of this inability to identify appropriate genes we
expanded our search to include genes that were within 250 Kb of each ET SNP.
Although we discovered no genes associated with Type 2 diabetes mellitus using the
most stringent threshold, we did find one gene with the 90th/10th threshold, BHMT,
that has been putatively associated with diabetes (β = 0.26; p value 5.9 × 10−3) [23].
Under the 95th/5th percentile threshold, we found only seven ET SNPs which mapped
to four genes. None of these four genes had evidence of genetic association with any
phenotype, to date. Using the 90th/10th percentile threshold, we identified 164 ET SNPs
that mapped to 115 genes. Again, none of these genes were associated with any disease
having the expected population distribution. Under the 85th/15th percentile threshold,
we identified 407 ET SNPs that mapped to 233 genes. Of these genes, two had prior
evidence of association with diseases with the appropriate population distributions. Both
genes, XG and NLGN4X, are related to autism spectrum disorders that are also appropri-
ately distributed among these populations (Additional file 1: Table S1). The p value of the
most significant SNP in XG was 3.79 × 10−8 in a family based GWAS [24]. In contrast, in
NLGN4X the smallest p value was 0.024 in a candidate gene study [25]. We also found a
gene, SHROOM2, that is associated with an Alzheimer’s disease endophenotype, but the
GWAS study describing this association only generated a p value of 0.0003 [26].
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To assess whether ET significantly enriched for genes associating with our index and
other appropriately distributed phenotypes, we perfomed random resampling of the
genome to estimate an empiral p value. We then interrogated HuGE Navigator to
identify associations and tested whether our randomly sampled genes were associated
with either our index phenotypes or other traits similarly distributed among the
respective populations. From the CEU, GIH and YRI ET analyses for melanoma, for the
most stringent threshold, four out of the 33 identified genes were known to be associ-
ated with phenotypes appropriately distributed among the three populations (Table 2).
For the next two thresholds, the results were 15 out of 230 genes and 49 out of 971
genes. Our random resampling determined in all three of these cases that ET signifi-
cantly enriched for genes that associated with appropriately distributed diseases/traits,
with the p-value being more significant for the less stringent thresholds (Table 2).Comparison to population branch statistic
An existing method, Population Branch Statistic (PBS) also integrates evolutionary
comparisons among three populations to search for candidate genes and has been
successful in identifying genes related to high altitude adaptation [27]. PBS uses two
populations with known differences in phenotype prevalence and a third random out-
lier population to identify genes likely to associate with a predefined trait. Variants that
show high allele frequency differentiation in only one of the two pre-selected popula-
tions are assumed to be under selection, reflected by high PBS scores. Unlike our
method, there is no phenotype prevalence restriction on the outlier population. We
compared ET with PBS to determine if adding the phenotypic prevalence in the third
population increases our ability to find disease associating genes. To do this, we first
chose CEU and YRI as the two pre-selected populations, then ran PBS analysis using
all other available HapMap III populations as the outlier. We selected the top 22 SNPs
from PBS (based on the most stringent CEU-YRI-GIH comparison from ET) to assess the
performance against ET. SNPs with the highest PBS scores were picked for each popula-
tion and then were mapped to genes within ± 100 Kb (Additional file 9: Table S7). To
determine association, we applied the same criteria as described above for our ET
analyses. We found that, at most, three genes, SLC12A1, SLC45A2 and AMACR, are
associated with phenotypes that are appropriately distributed between European and West
African populations, two of which had been observed using ET. In other analyses using
MEX, TSI, GIH, ASW, LWK and MKK as outlier populations, only one appropriate gene
was identified, SLC12A1. Using CHD and JPT as outlier populations, we identified no















95th/5th 22 33 6 4 0.0237
90th/10th 168 230 27 15 0.0111
85th/15th 733 971 42 49 0.0023
Huang et al. BioData Mining  (2016) 9:12 Page 11 of 18identify four genes relevant to diseases (Table 2). It is likely that ET performed better in
most cases because we explicitly added a third population with known disease prevalences
and this additional information appeared to increase our resolving power.Discussion
ET’s performance is related to effect size
In this manuscript, we addressed whether population differences shaped by evolutionary
histories can be used to identify or enrich for genes associated with phenotypes that are
differentially distributed. We hypothesized that comparing three populations, using the
ET algorithm, can enrich for variants or genes that can be compared to standard associ-
ation results, helping define those of greater interest with respect to phenotype. This, in
essence, is an additional filtering method that may allow us to relax standard association
significance thresholds, such that we can identify putative disease associating variants that
can be targeted for follow-up, even if they do not reach standard genome-wide association
significance. In our analyses, we focused on three different phenotypes that are both dif-
ferentially distributed and have putatively different genetic architectures. ET’s
performance appeared to differ among these phenotypes. For the trait with the simplest
genetic architecture, lactase persistence, ET was robust; ET defined the causative genetic
region using several population comparisons that matched the distribution of lactase per-
sistence [9, 28]. For likely oligogenic phenotypes such as melanoma, ET performed well.
Assuming that the number of GWAS hits in each of these two diseases is correlated with
the complexity of the genetic models (one for lactase persistence and 22 for melanoma),
we can see that as the effect sizes decrease and the number of associating genes increases,
which, presumably, is correlated with increasing complexity of the genetic architecture,
ET was less effective in identifying previously known genes [29, 30]. It may also be pos-
sible that ET is best suited to detect loci that may not only be associating with diseases
that are differentially distributed, but with loci that differentiated due to selection, as is
the case with genes for lactase persistence and melanoma. Interestingly, standard GWAS
found multiple signals for lactase persistence, but after adjusting for ancestry all except
LCT, which was identified by ET, became non-significant, demonstrating that ET does not
conflate ancestry with association [29].
Regardless of the FST threshold, ET clearly showed an enrichment for melanoma
genes compared to the random resampling analysis, emphasizing its utility. It is also
interesting that ET did significantly enrich for genes associated with several other dis-
eases that shared the same prevalence pattern and are presumably related to melanoma.
Multiple sclerosis, although sharing the same geographic distribution as melanoma,
does not appear to be as good a candidate disease for ET analysis. However, MS
appears to be more genetically complex based on the number and effect sizes of genes
already identified as associating with it (Additional file 2: Table S2). Although we did
identify some genes related to MS, we were not able to see an enrichment for them.
MS also appears to be more affected by environmental variation, and risk can change
with migration during early adolescence, thereby serving as a modifier of genetic risk
[31]. Another important finding from ET in the melanoma analyses is the identification
of G6PD. This is of particular interest as G6PD deficiency is known to protect from
malarial infection [20, 32–34], although it was not found in the GWAS for malaria
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GWAS is likely an artifact of poor coverage in this genic region as well as low
frequency of the protective alleles in the studied populations. Nonetheless, this demon-
strates the potential of ET, to not only refine, but in some cases, to identify important
signals missed by standard association that are included in publically available
databases but absent from genotyping arrays.
For phenotypes that are polygenic, with putative small effect sizes such as fasting
glucose or Type 2 diabetes mellitus, ET’s utility appeared to be more limited. Specifically,
the role of environment in confounding the ability of ET to identify risk genes may be
seen in diabetes, as the prevalence of Type 2 diabetes is increasing, presumably because of
the adoption of lifestyles that promote it. Therefore, even if there are strong diabetes
genes in a few environments, their action may not be detectable in many modern human
societies where the effect of the environment has become preeminent and time has been
inadequate to differentiate genes affecting this phenotype. We may, therefore, conclude
that as the environment’s recent role in disease increases, the ability of ET to identify key
genes will decrease. This should correlate with the length to which a population has been
exposed to a new environment. This is not a feature unique to ET, as this will be the case
even with standard association approaches. Nonetheless, even though ET and standard
association methods differ substantially in their underlying assumptions and metrics, they
may still be used to support each other [36]. In cases where there is significant locus het-
erogeneity among cohorts, ET may be extremely useful in helping to identify interesting
associations in subsets of data that are often ignored in large GWAS meta-analyses.
Therefore, despite that fact that ET did not enrich for known diabetes genes, it may have
enriched for previously undetected diabetes genes, and can be used to provide additional
evidence for follow-up. As with other approaches, ET is not as useful for detecting
variants that are rare in all populations, as association offers low power in detecting
differences. However, we emphasize that all current population-based designs suffer from
this limitation and are unlikely to be practical for the statistical detection of rare variants
that associate with disease. Family based (linkage) approaches to identifying rare disease
associated genes are still the preferred method in these cases.ET as an agnostic filter
GWAS have been used to examine almost every common complex disease, and
although many SNPs have been dismissed because they do not meet standard multiple
testing correction thresholds, it is probable that many of them truly associate with the
disease. The detection of these SNPs represents a major challenge in our developing
understanding of disease etiology because the current methods produce inflated Type
II errors. Thus, although GWAS have been able to discover significant hits in certain
diseases, its success is limited in most situations and probably represents the limitations
of only using p values for biological data mining [37], making association result filtering
based solely on p value problematic. Therefore, it is important to develop methods that
can minimize this type of error while still controlling for the Type I error rate. One
way to do this is to integrate knowledge from independent analyses [36]. Integration of sev-
eral data types has been successful in the analysis of diseases, such as MS [38]. However,
pathway-oriented filtering, such as for MS in Baranzini et al., requires prior knowledge of
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alternative filtering metric based, not on prior biological knowledge, only on evolutionary
history that shaped biology. ET also has an advantage over some standard association
analyses because, if a variant that increases risk is fixed in a population that has a higher
prevalence (i.e., is an etiological agent), it would not be detected in association analyses;
however, ET may identify it. A key to the success of ET is having at least three populations,
since comparing only two would produce an enormous number of false positives, while
adding a third population can reduce this number.
ET only requires knowledge of allele frequencies and disease distributions, but the
latter may be a limiting factor for many diseases, but this will change with better sur-
veillance. However, limited surveillance is not the only factor that may affect the utility
of ET. For example, variable diagnoses across countries may present an issue as will
changing definitions of disease phenotypes over time. The latter will make comparisons
over time difficult. The issue of ethnic variation in disease prevalence may, however, be
partially ameliorated in coutries that have highly diverse populations, such as the US
where data on many continental populations can be collected simultaneously and used
to define appropriate ET populations, but this is still not as robust as would be ideal as
many populations in such situations are highly admixed. As ET detects differences in
local variation the method should still be powerful for the detection of genes that affect
disease risk in all populations, i.e. universal genetic risk factors. However, in epistatic
models of disease it may not be possible to detect all key genes when local ancestry
varies elsewhere in the genome [39].Combining FST with other metrics
In this study, we used only FST as a metric of population differentiation. FST is computa-
tionally straightforward and thus makes our model easily applied in any population
comparisons. Since genetic differentiation could be due to both selection and random drift,
and FST does not explicitly differentiate between these two processes, extensions of ET that
include measures of selection may be useful for future analyses. An existing statistic that
can be used to provide evidence for selection is iHS [40] (http://haplotter.uchicago.edu/).
We investigated iHS patterns in the genomic regions identified in our study using the most
stringent FST thresholds among CEU, YRI and GIH. In most regions the iHS scores were
larger in CEU than in YRI and ASN (the East Asian HapMap population), indicating
stronger selection signals in the CEU population (Additional file 10: Table S8). Clearly,
integrating the role of selection into the ET analyses in the future will be an important
extension of the method.
Selection may be an important factor in shaping the distribution of disease risk al-
leles; however, it is not always the mechanism through which important differentiation,
which affects phenotypic variation, takes place. One strong example of this is the LCT
locus, which has been shown by multiple metrics to be under selection in multiple
populations and was identified by ET in our study [9, 41]. Another example of a
selected locus affecting disease risk that was identified by ET is APOL1. This gene has
been shown to be under selection in African populations, due to protection against
human African trypanosomiasis [42]. Different metrics may be able to pick up different
signals indicating selection (e.g., Cross Population Extended Haplotype Homozygosity
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with comparatively simple genetic architecture in which selection appears to be important
in shaping population structure, the role of selection in Type 2 diabetes mellitus is less
clear. Recent studies of Type 2 diabetes mellitus genes have indicated that they are not
under selective pressure among multiple human populations [46, 47]. However, another
paper studying the distribution of Type 2 diabetes mellitus risk alleles indicates that
random drift alone has not shaped diabetes’ genetic risk differences from Africa to East
Asia [48], making it difficult to draw strong conclusions at this point. Understanding the
role of non-random processes in shaping disease risk will be an important area of
research, especially as it affects disease disparity among continental populations in
changing environments.Possible pleiotropy in ET genes
In our analyses of ET genes and their associated diseases, it became obvious that several
of the genes identified are risk factors for multiple diseases. Among the genes from the
least stringent ET threshold among CEU, YRI and GIH, we discovered that several
genes were associated with multiple diseases and traits (Tables 1, Additional file 8:
Table S6). For example, IL6 has been associated with 15 phenotypes that are appropri-
ately distributed and IFNG with seven. Both genes are related to immune response,
among other processes. It is possible that selection has been important in changing
allele frequency distributions, while at the same time having multiple pleiotropic effects
that may or may not have been directly driven by selection. Another example is the
genes related to melanoma, as they are also associated with skin color, eye color and
albinism (SLC45A2 [49, 50]), preterm birth (DHCR7 [51]), and Vitamin D levels (NAD-
SYN1 [21]). Interestingly, an ET gene from the most stringent threshold, BNC2, has
also been associated with hair and skin color [22, 52, 53]. In this specific case, it seems
that skin color is a confounder of other genetic effects. As humans migrated to higher
latitudes with insufficient UV radiation, lighter skin color facilitated more vitamin D
synthesis in the skin. However, this increased the risk of melanoma. Although having
less than five publications indicating associations, BNC2 has also been associated with
ovarian cancer in two GWAS, both reaching genome wide significance [54, 55]. We do
note that our calculations of the number of associating genes, with appropriately
distributed phenotypes, were conservative; each gene was counted only once, even if it
associated with multiple pleiotropic phenotypes.Comparisons to other related methods
Models developed in different studies employ similar evolutionary mindsets to what we
have discussed. PBS does not require a specific phenotype prevalence pattern on the
third population in the three population comparison, which may make it less powerful
than ET in identifying disease associating genes. On the other hand, Hancock et al. [56]
reported that correlations between allele frequencies and climate variables can be
applied to detect SNPs associating with pigmentation and autoimmune diseases. In this
case, they were looking for local selection due to environmental factors chosen a priori,
whereas ET is not limited to specific factors that give rise to the disease prevalence
distribution pattern.
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phenotype based on how much additional information is provided by phenotype to infer
the geographic origin compared to information provided without genotypes [57].
However, this method requires the phenotype, which is height, to be known for every
individual. In our method, we only need to compare disease risk at the population level.Conclusions
Evolutionary thinking can provide important insights for biomedical research; when
combined with current approaches commonly employed in human disease studies, it
can increase our ability to find key genes or pathways that affect etiology. By taking ad-
vantage of both epidemiological differences and population structure, we demonstrated
that many genes associating with diseases can be found. This paper presents a proof of
principle for this approach, as well as some of its limitations. Clearly, for phenotypes
with simple genetic architecture, ET is an extremely powerful approach, but this
becomes less practical for traits of increasingly complex architecture. Nonetheless, for
several traits, we were able to identify genes with known effects. It is also possible that
many more of the ET genes are truly associating, but have not been reported as such, as
they do not meet current thresholds for significance. Therefore, we propose that ET can
be a useful filter with which to interrogate existing and new association studies for
consistent patterns that might lead to the identification of additional genetic risk factors.
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